Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2659

Actual shortage: 251 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2399 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

27 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65996
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
TEVA-TELMISARTAN 40MG TABLET Resolved 2018-11-20 2019-04-11 67219
TEVA-TELMISARTAN 40MG TABLET Resolved 2018-11-20 2020-06-04 67222
TEVA-TELMISARTAN 80MG TABLET Resolved 2018-11-20 2020-05-08 67225
TEVA-TELMISARTAN 80MG TABLET Resolved 2018-11-20 2020-05-08 67228
TEVA-TELMISARTAN 80MG TABLET Resolved 2018-11-20 2020-05-14 67231
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2018-11-20 2019-04-27 67234
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2018-11-20 2019-07-15 67237
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2018-11-20 2019-04-27 67240
TEVA-TELMISARTAN HCTZ 25.0MG 80.0MG TABLET Resolved 2018-11-20 2019-03-12 67243
TEVA-TELMISARTAN HCTZ 25.0MG 80.0MG TABLET Resolved 2018-11-20 2019-03-12 67246
TEVA-AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-10 68572
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2020-02-13 68577
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-11-22 68580
ACT CELECOXIB 200MG CAPSULE Resolved 2018-12-04 2019-04-11 68583
ACT CELECOXIB 200MG CAPSULE Resolved 2018-12-04 2019-08-06 68586
ACT DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2018-12-04 2019-06-04 68589

Showing 561 to 580 of 2659

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ATENOLOL 100MG TABLET Discontinued 2020-02-13 2020-02-13 106145
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2020-02-13 2020-02-13 106148
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2020-02-13 2020-02-13 106158
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2020-02-13 2020-02-13 106161
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2020-02-13 2020-02-13 106164
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2020-02-13 2020-02-13 106167
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-PAROXETINE 10MG TABLET Discontinued 2020-02-21 2020-02-21 106898
TEVA-PAROXETINE 30MG TABLET Discontinued 2020-02-21 2020-02-21 106901
ACT RANITIDINE 150MG TABLET Discontinued 2020-05-14 2020-05-14 115079
ACT RANITIDINE 300MG TABLET Discontinued 2020-05-14 2020-05-14 115082
TEVA-ARIPIPRAZOLE 2MG TABLET Discontinued 2020-05-14 2020-05-14 115085
CEFOXITIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2020-05-14 2020-05-14 115088
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091
ACT DILTIAZEM T 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115114
ACT DILTIAZEM T 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115117

Showing 161 to 180 of 250